What is BIOAF's gross margin?

Bioasis (BIOAF) has a gross margin of -48% and a net margin of -662%.

What is BIOAF's P/E ratio?

Track Bioasis (BIOAF) P/E ratio, ROE, and valuation metrics over time.

Where can I see BIOAF's full financials?

See Bioasis (BIOAF) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Bioasis (BIOAF) Financials — Revenue, Earnings, Cash Flow

Also trades as: BTI.V (TSXV) · $vol 0M

$0.00

+0.00 (+0.00%)

OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 49 · $7941 mcap · 78M float · 0.087% daily turnover · Short 100% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$0M

Revenue

+614.1% YoY

$-3M

Net Income

+17.5% YoY

$-2M

Free Cash Flow

+10.6% YoY

-48.3%

Gross Margin

-469.2%

Op. Margin

-661.8%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE135.1%

ROA-120.6%

ROIC538.8%

Valuation

P/E-0.1

P/B-0.2

EV/EBITDA0.0

Leverage

Debt/Equity-0.82

Current Ratio0.11

Interest Cov.-3.4x

Quality Scores

Piotroski F2/9

Altman Z—

Beneish M1.03